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Partial sequencing and expression of genes involved in glucose
metabolism in adipose tissues and skeletal muscle of healthy cats
Abstract
Impaired insulin sensitivity is increasingly recognised in cats, but sequences of genes involved in
insulin-signalling are largely undetermined in this species. In this study, extended feline mRNA
sequences were determined for the adiponectin, glucose transporter-1 (GLUT1), GLUT4, peroxisome
proliferative activated receptor-gamma1 (PPARgamma1), PPARgamma2, plasminogen activator
inhibitor-1 (PAI-1), monocyte chemoattractant protein-1 (MCP-1) and insulin receptor genes.
Conserved dog-specific primers identified from human-dog mRNA alignments were used to amplify
feline cDNA in the polymerase chain reaction (PCR). The feline sequences determined by this method
were used to design feline-specific primers suitable for real-time PCR for quantification of gene
expression in insulin sensitive tissues of healthy cats. Partial sequences of feline mRNAs had 86-95%
identity with dog and human genes. Expression of adiponectin, GLUT1, GLUT4, PPARgamma1,
PPARgamma2, PAI-1 and insulin receptor mRNA was detected and quantified in subcutaneous and
visceral fat and skeletal muscle, whereas MCP-1 mRNA was detected in adipose tissue but not in
skeletal muscle. Further characterisation of genes related to glucose metabolism in cats will provide
additional insights into insulin-signalling mechanisms in this species.
 1
Original article 1 
 2 
Partial sequencing and expression of genes involved in glucose metabolism in adipose 3 
tissues and skeletal muscle of healthy cats 4 
 5 
 6 
Eric Zini a,*, Philippe Linscheid a, Marco Franchini b, Karin Kaufmann a, Edouard Monnais a, 7 
Annette P. Kutter c, Mathias Ackermann b, Thomas A. Lutz d, Claudia E. Reusch a 8 
 9 
a Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zürich, 10 
Winterthurerstr. 260, 8057 Zürich, Switzerland 11 
b Institute of Virology, Vetsuisse Faculty, University of Zürich, Winterthurerstr. 266a, 8057 12 
Zürich, Switzerland 13 
c Equine Clinic, Section of Veterinary Anaesthesia, Vetsuisse Faculty, University of Zürich, 14 
Winterthurerstr. 260, 8057 Zürich, Switzerland 15 
d Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zürich, Winterthurerstr. 16 
260, 8057 Zürich, Switzerland 17 
 18 
 19 
 20 
 21 
* Corresponding author. Tel.: +41 44 6358746; fax: +41 44 6358930. 22 
 E-mail address: ezini@vetclinics.uzh.ch (E. Zini). 23 
 2
Abstract 24 
Impaired insulin sensitivity is increasingly recognised in cats, but sequences of genes 25 
involved in insulin-signalling are largely undetermined in this species. In this study, extended 26 
feline mRNA sequences were determined for the adiponectin, glucose transporter-1 (GLUT1), 27 
GLUT4, peroxisome proliferative activated receptor-γ1 (PPARγ1), PPARγ2, plasminogen 28 
activator inhibitor-1 (PAI-1), monocyte chemoattractant protein-1 (MCP-1) and insulin 29 
receptor genes. Conserved dog-specific primers identified from human-dog mRNA 30 
alignments were used to amplify feline cDNA in the polymerase chain reaction (PCR). The 31 
feline sequences determined by this method were used to design feline-specific primers 32 
suitable for real-time PCR to quantify gene expression in insulin sensitive tissues of healthy 33 
cats. Partial sequences of feline mRNAs had 86-95% identity with dog and human genes. 34 
Expression of adiponectin, GLUT1, GLUT4, PPARγ1, PPARγ2, PAI-1 and insulin receptor 35 
mRNA was detected and quantified in subcutaneous and visceral fat and skeletal muscle, 36 
whereas MCP-1 mRNA was detected in adipose tissue but not in skeletal muscle. Further 37 
characterisation of genes related to glucose metabolism in cats will provide additional insights 38 
into insulin-signalling mechanisms in this species. 39 
 40 
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Introduction 42 
Similar to human type 2 diabetes mellitus, cats can develop an obesity-associated form 43 
of diabetes mellitus with similar clinical features, including peripheral insulin resistance and 44 
disturbed insulin production (Feldhahn et al., 1999; Appleton et al., 2001). The current 45 
dramatic increase in obesity in humans has triggered research directed at understanding the 46 
molecular mechanisms linking obesity with the development of insulin resistance, 47 
hypertension and atherosclerosis. Low chronic inflammation is increasingly recognised as a 48 
possible link, but the precise molecular mechanisms remain poorly understood (Wellen and 49 
Hotamisligil, 2005). 50 
 51 
It has been hypothesised that increased expression of inflammatory cytokines, such as 52 
tumour necrosis factor-α and interleukin-6, dysregulate a number of genes important in lipid 53 
metabolism and glucose homeostasis (Wellen and Hotamisligil, 2005). In cats, data on 54 
expression of genes involved in glucose metabolism are scarce and several feline-specific 55 
insulin signalling-associated genes have yet to be sequenced (Brennan et al., 2004; Hoenig et 56 
al., 2007). 57 
 58 
Adiponectin is a circulating factor with insulin-sensitising and anti-inflammatory 59 
properties that is mainly expressed in adipocytes and liver (Kadowaki et al., 2006). Lower 60 
levels of adiponectin expression are detected in skeletal muscle (Yang et al., 2006). A strong 61 
inverse association has been observed between circulating levels of adiponectin and obesity in 62 
humans and cats (Yang et al., 2001; Brennan et al., 2004). 63 
 64 
Glucose transporter-1 (GLUT1) is ubiquitously expressed, whereas GLUT4 is 65 
expressed predominantly by insulin-sensitive cells, including myocytes and adipocytes (Wood 66 
 4
and Trayhurn, 2003). GLUT4 expression may be decreased in type 2 diabetes mellitus in 67 
humans and in obesity in humans and cats (Brennan et al., 2004; Wellen and Hotamisligil, 68 
2005). Conversely, GLUT1 expression is either increased or unaffected in these conditions 69 
(Miele et al., 1997; Brennan et al., 2004). 70 
 71 
Peroxisome proliferative activated receptors (PPARs) are nuclear receptors that act as 72 
transcriptional regulators of nutrient metabolism and energy homoeostasis (Lagathu et al., 73 
2003). Three major PPAR isoforms (α, β/, and γ) have been identified, with splicing variants 74 
reported for all three subtypes. PPARγ is a key nuclear receptor during adipocyte 75 
differentiation (Hamm et al., 2001). While the splice variant PPARγ1 is found in several cells, 76 
PPARγ2 is mainly adipocyte-derived, with lower amounts detected in skeletal muscle (Vidal-77 
Puig et al., 1997; Wagatsuma, 2006). Studies involving knockout mice and synthetic PPARγ 78 
ligands (i.e., thiazolidinediones) have demonstrated the crucial role of this nuclear receptor in 79 
maintaining insulin sensitivity and reducing cytokine expression (Semple et al., 2006). 80 
 81 
Plasminogen activator inhibitor-1 (PAI-1) is a member of the serine protease inhibitor 82 
family known for its ability to inhibit fibrin clot breakdown (De Taeye et al., 2005). 83 
Monocyte chemoattractant protein-1 (MCP-1) is a member of the chemokine family which 84 
plays a crucial role in the recruitment of monocytes in tissues (Herder et al., 2006). Even 85 
though many cells express PAI-1 and MCP-1, growing evidence suggests that adipocytes are 86 
a primary source of these molecules in the circulation (De Taeye et al., 2005; Herder et al., 87 
2006). In obese rats and humans, PAI-1 and MCP-1 are over-expressed by adipose tissue and 88 
have been shown to contribute to the development of insulin resistance and type 2 diabetes 89 
mellitus (De Taeye et al., 2005; Herder et al., 2006). Insulin-stimulated activation of the 90 
insulin receptor is the first step in the mechanism controlling glucose homeostasis. Defective 91 
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receptor signalling in insulin target tissues (e.g., muscle, adipose tissue and liver) impairs 92 
insulin sensitivity (Denley et al., 2003). 93 
 94 
The aim of this study was to determine new sequences (GLUT1, GLUT4, PPARγ1, 95 
PPARγ2, PAI-1, MCP-1 and insulin receptor) or to extend known sequences (adiponectin) of 96 
feline-specific genes which have a potential relationship to the generation of inflammation-97 
induced insulin resistance. The sequences identified in this study were used to establish real-98 
time polymerase chain reaction (PCR) to detect and quantify the expression of mRNAs in 99 
insulin sensitive tissues of healthy cats, including subcutaneous and visceral adipose tissue 100 
and skeletal muscle. 101 
 102 
Materials and methods 103 
Animals and tissue biopsies 104 
A group of 19 healthy neutered male domestic short haired cats, 1.5-4 years old 105 
(median 2.8 years) and weighing 4.2-5.5 kg (median 4.8 kg), were maintained at the animal 106 
care facility of the Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University 107 
of Zürich, Switzerland. Animal studies were approved by the Cantonal Veterinary Office of 108 
Zürich (95/2006). Cats were determined to be healthy on the basis of physical examination 109 
and clinical laboratory data. 110 
 111 
Tissue biopsies were collected under general anaesthesia. The cats were fasted for 12 112 
hours and acepromazine (50 µg/kg) and buprenorphine (15 µg/kg) were administered IM for 113 
sedation and analgesia. After 30 min, anaesthesia was induced with propofol (6 mg/kg) IV, 114 
the cats were intubated with a cuffed endotracheal tube and anaesthesia was maintained with 115 
isoflurane administered to effect. Biopsies (100-150 mg) were collected from visceral and 116 
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subcutaneous fat and from skeletal muscle, rapidly frozen in liquid nitrogen and stored at 80 117 
C until further use. Visceral fat was collected from near the jejunum, subcutaneous fat was 118 
collected from the inguinal area and skeletal muscle was collected from the vastus lateralis 119 
muscle. After the procedure, all cats recovered uneventfully. Buprenorphine (20 µg/kg) was 120 
administered every 6 h on the first day to obtain analgesia and then according to individual 121 
needs. For bacterial prophylaxis, oral amoxicillin was administered at 10 mg/kg BID for 5 122 
days. 123 
 124 
RNA isolation and reverse transcription 125 
Total RNA from visceral and subcutaneous fat was extracted using RNeasy Mini Kit 126 
(Qiagen). Samples (30 mg) were disrupted and homogenised using the Mixer Mill MM 300 127 
(Qiagen) for 1 min at 30 Hz. Total RNA isolation from feline skeletal muscle was performed 128 
using RNeasy Fibrous Tissue Mini Kit (Qiagen) and the Mixer Mill MM 300 (Qiagen) for 2 129 
min at 20 Hz. Possible genomic DNA contamination in tissue-derived RNA samples was 130 
eliminated by including DNase-treatments (DNase-Free DNase Set, Qiagen). RNA was 131 
quantified spectrophotometrically (ND-1000 Spectrophotometer, NanoDrop) and the quality 132 
was assessed by identifying 18S and 28S rRNA bands on gel electrophoresis. cDNA was 133 
obtained from 1 g samples of tissue-derived RNA (Omniscript RT Kit, Qiagen) in the 134 
presence of 13 U of RNasin (Promega). cDNA was subjected to PCR using PCR Taq core kit 135 
(Qiagen) on a conventional thermal cycler (T-personal, Biometra). 136 
 137 
Partial sequencing of feline-specific mRNAs 138 
Conserved sections of adiponectin, GLUT1, GLUT4, PPARγ1, PPARγ2, PAI-1, 139 
MCP-1 and insulin receptor mRNAs were identified from human and canine sequence 140 
alignments. Using canine sequences, PCR primers were designed with a web-based tool 141 
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(http://bibiserv.techfak.uni-bielefeld.de/genefisher/). Feline adipose tissue and skeletal 142 
muscle-derived cDNAs were subjected to PCR amplification with canine primer pairs located 143 
in conserved sections (Table 1). A total volume of 25 μL contained 1 μL cDNA template, 0.2 144 
mM dNTPs, 0.025 units/μL Taq DNA polymerase and 1x reaction buffer (PCR Taq Core Kit, 145 
Qiagen), with specific sense and antisense primers, each at a final concentration of 300 nM. 146 
To perform the PCR, an initial denaturation step of 30 s at 94 °C was followed by an 147 
annealing of 45 s at 60 °C and extension of 60 s at 72 °C. Forty cycles of PCR were used for 148 
each target. 149 
 150 
When present, multiple amplicons were eliminated by optimising PCR conditions or 151 
by replacing the primers until single products of the expected size were obtained. Amplicons 152 
were purified with QIAquick PCR purification kit (Qiagen) and both strands were sequenced 153 
using the same primers (Microsynth). Corresponding protein sequences were deduced from 154 
mRNA using on-line software (http://www.expasy.org/). 155 
 156 
Quantitative analysis of mRNA 157 
cDNA obtained from feline tissues was subjected to quantitative real-time PCR 158 
analysis using feline-specific intron spanning oligonucleotides (Table 2) and the iCycler iQ 159 
sequence detection system (BioRad). Primers for adiponectin, GLUT1, GLUT4, PPARγ1, 160 
PPARγ2 PAI-1, MCP-1 and insulin receptor gene sequences were designed within the newly 161 
determined feline-specific partial mRNA sequences using Primer Express 3.0 software 162 
(Applied Biosystems). Primer pair selection criteria were set to generate short amplicons (85-163 
162 bp) with annealing temperature, as well as secondary structure, suitable for SYBRGreen 164 
real-time PCR detection. For detection of feline-specific glyceraldehyde-3-phosphate 165 
dehydrogenase (GAPDH) mRNA, published oligonucleotides were used (Kipar et al., 2001). 166 
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PCR reactions were prepared with 10 μL Power SYBR-Green Master Mix (Applied 167 
Biosystems), a final concentration of 500 nM of each primer and 5 μL of template diluted 1:5 168 
in a total reaction volume of 20 μL. 169 
 170 
An initial denaturing step was performed for 10 min at 95 °C, followed by 40 cycles of 171 
95 °C for 15 s and 60 °C for 1 min, then 95 °C and 60 °C for 1 min each and 80 cycles of 10 172 
s, starting from 60 °C with a 0.5 °C increase after each cycle. At the end of the programme, 173 
PCR product identity was confirmed by melting curve analysis and DNA sequencing 174 
(Microsynth). 175 
 176 
Parallel reactions were performed in duplicate for every feline cDNA sample. Two 177 
template-free controls and duplicates without reverse transcriptase were included in every 178 
amplification run. For each reaction, duplicate standard curves were generated with serial 179 
dilutions of the purified specific PCR product previously obtained by conventional PCR with 180 
the same primers. Target gene mRNA was quantified using the relative standard curve 181 
method (Perkin-Elmer Cetus User Bulletin no. 2, 1997). Gene expression was normalised to 182 
the respective quantities of GAPDH. 183 
 184 
Transcripts of adiponectin, GLUT1, GLUT4, PPARγ1, PPARγ2, PAI-1, MCP-1 and 185 
insulin receptor were studied in each tissue by repeated measures ANOVA with post-hoc 186 
Bonferroni correction to compare relative expression between adipose tissues and skeletal 187 
muscle of healthy cats. The level of significance was set at P<0.05. 188 
 189 
Results 190 
Partial mRNA sequences of glucose metabolism-related genes in cats 191 
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By applying a PCR-based approach we partially determined the feline-specific mRNA 192 
sequences and deduced the corresponding protein sequences of GLUT1, GLUT4, PPARγ1, 193 
PPARγ2, PAI-1, MCP-1 and insulin receptor. In addition, we extended the known partial 194 
mRNA sequence of feline adiponectin (Fig. 1 and 2). The GenBank accession numbers and 195 
mRNA and protein similarities to canine and human sequences are given in Table 3. 196 
 197 
mRNA expression in insulin sensitive tissues in cats 198 
Expression of adiponectin, GLUT1, GLUT4, PPARγ1, PPARγ2, PAI-1 and insulin 199 
receptor was successfully quantified in adipose tissue and muscle of healthy cats. With feline-200 
specific primers, MCP-1 mRNA was detected in subcutaneous and visceral fat, but in most 201 
samples of skeletal muscle melting curves showed 1-2 additional peaks or a single broad peak 202 
with a lower melting temperature. Therefore, the primers designed for MCP-1 were not 203 
considered to be suitable for transcript quantification in feline skeletal muscle. 204 
 205 
Visceral adipose tissue had significantly higher levels of mRNA expression of 206 
adiponectin, GLUT1, GLUT4 and PPARγ2 than subcutaneous adipose tissue. All targets had 207 
lower levels of mRNA expression in skeletal muscle than in subcutaneous or visceral fat 208 
(Table 4). 209 
 210 
Discussion 211 
To explore glucose metabolism in obese and diseased cats, it is important to develop 212 
molecular tools to investigate transcriptional changes that occur in insulin sensitive tissues. 213 
For this purpose, based on current knowledge of the pathogenesis of obesity and type 2 214 
diabetes mellitus, we determined gene sequences and designed primers for quantification of 215 
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levels of mRNA of relevant glucose metabolism-related genes. Normal levels of expression of 216 
these genes were determined in adipose tissues and skeletal muscle of healthy cats. 217 
 218 
In this study, we determined seven new feline-specific partial mRNA sequences of 219 
insulin signalling-related genes and elongated the known feline adiponectin sequence. Feline 220 
cDNA was amplified by PCR using canine specific primers determined from conserved 221 
regions in canine and human sequence alignments. In approximately 85% of cases, we 222 
obtained single amplicons that could be directly sequenced without the need to clone into a 223 
vector. Even though complete feline cDNA sequences were not obtained, high similarities 224 
(86-95% identity) were evident among feline, canine and human gene sequences (Table 3). 225 
Similar or even higher degrees of sequence identity (81-98%) were observed for the deduced 226 
corresponding protein sequences. As expected from the closer phylogenetic relatedness of 227 
cats and dogs, feline sequences exhibited a higher degree of similarity to canine than to 228 
human sequences. 229 
 230 
Feline-specific PCR primers nested within the newly determined mRNA sequences 231 
were tested using cDNA derived from adipose tissue and skeletal muscle of healthy cats. 232 
Primer pairs for adiponectin, GLUT1, GLUT4, PPARγ1, PPARγ2, PAI-1 and insulin receptor 233 
were appropriate to quantify cDNA transcripts in each of the examined insulin sensitive 234 
tissues. Primers for MCP-1 were suited for mRNA quantification in subcutaneous and 235 
visceral fat but not in skeletal muscle. 236 
 237 
The reverse transcriptase-PCR procedures were established in order to advance 238 
knowledge on disorders of glucose metabolism in cats. The prevalence of diabetes mellitus in 239 
cats is 1/50-1/400 and recent evidence suggests that the incidence is increasing (Panciera et 240 
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al., 1990; Baral et al., 2003). Predisposing factors, such as obesity due to overfeeding and 241 
physical inactivity, have increased dramatically in the feline population (Rand et al., 2004). In 242 
the cat and several other species, obesity promotes insulin resistance and increases the 243 
workload of pancreatic islet -cells, ultimately leading to -cell exhaustion and development 244 
of overt diabetes mellitus (Appleton et al., 2001; Wellen and Hotamisligil, 2005). 245 
 246 
Conclusion 247 
In this study, feline-specific mRNA sequences of several insulin signalling-related 248 
genes were determined. Primers were designed for quantification of levels of expression of 249 
these genes in tissues by real-time PCR. These tools should prove useful for future studies on 250 
gene dysregulation and metabolic abnormalities in disorders causing impaired insulin 251 
sensitivity, such as diabetes mellitus, in cats. 252 
 253 
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Tables 
 
Table 1 
Primers used for amplification of feline cDNAs 
 
Gene Sense (5′-3′) Antisense (5′-3′) Approximate product size 
(bp) 
Adiponectin GGCCTGGAGTCCTGCTTCCC GTACTGGTCATAGGTGAAGAG 500 
GLUT1 GGGCTTCTCGAAACTGGGCAA GGCTCGGCTGACATCTGTCA 1,250 
GLUT4 AAGATGCCGTCGGGCTTCCA CTTCACCTCCTGCTCTAGAAGAGA 1,450 
PPARγ1 TCTCTCCGTAATGGAAGACC GCATTATGAGACATCCCCAC 450 
PPARγ2 GCGATTCCTTCACTGATAC GCATTATGAGACATCCCCAC 550 
PAI-1 TCGTCCAGCGGGATCTGAAGC GGGTCTGTCCATGATGATCTC 800 
MCP-1 TGCCTGCTGCTCATAGC CATGGAATCCTGGACCCACTT 250 
Insulin receptor TCTCCCAGAAAACCAGGTAGTG CATGGATATCCGGAACAACC 1,800 
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Table 2 
Feline-specific primers 
 
Gene Sense (5′-3′) Antisense (5′-3′) Product size (bp) 
Adiponectin CGGGTGAAAAGGGTGAGAAA TGAACGCTGAGCGGTATACG 162 
GLUT1 AGGAGAACCGGGCCAAGA AGCGGAACAGCTCCAGGAT 135 
GLUT4 TGGACGTGCAACTTCATCATC CAGAAGGACCGCGAACAGAA 90 
PPARγ1 GCCGTGTCTGTGGAGATAAAGC TCTGATTGTCCTCCGGAAGAA 89 
PPARγ2 GTCTGCAAGCACTTCACAAGAAA ATCCACGGAGCTGATTCCAA 85 
PAI-1 CAGAGCCAGGTTCATCGTCAA AGTAGAGGGCATTCACCAGCAT 122 
MCP-1 TGCAGAGGCTGGTGAGCTATAA TTGGGTCAGCGCAGATCTC 102 
Insulin receptor CTGCCCTGCCACTGTCATC GCAGACGGTCGGACAAACTT 85 
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Table 3 
GenBank accession number and mRNA and protein homology of genes investigated in the cat 
 
Canine identity Human identity Gene GenBank 
accession 
number 
mRNA Protein mRNA Protein 
Adiponectin DQ640898 93% 95% 88% 89% 
GLUT1 DQ640900 95% 98% 92% 97% 
GLUT4 DQ640899 90% 96% 90% 95% 
PPARγ1 DQ640901 95% 97% 92% 96% 
PPARγ2 DQ640902 95% 97% 92% 95% 
PAI-1 DQ835567 91% 94% 87% 88% 
MCP-1 DQ835566 93% 88% 86% 81% 
Insulin receptor DQ835565 94% 97% 88% 96% 
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Table 4 
mRNA quantities in insulin sensitive tissues of healthy cats 
 
Gene Subcutaneous fat mRNA Visceral fat mRNA Skeletal muscle mRNA 
Adiponectin 0.7 x 106 ± 0.2 x 106 1.3 x 106 ± 0.1 x 106 b 3.8 ± 0.5 * 
GLUT1 1.1 x 102 ± 0.3 x 102 3.2 x 102 ± 0.4 x 102 c 2.9 ± 0.6 * 
GLUT4 31.0 ± 7.6 48.6 ± 4.1 a 1.1 ± 0.1 * 
PPARγ1 9.2 x 103 ± 2.7 x 103 9.5 x 103 ± 1.8 x 103 8.6 ± 2.3 * 
PPARγ2 0.7 x 104 ± 0.2 x 104 1.5 x 104 ± 0.2 x 104 b 11.0 ± 3.1 * 
PAI-1 2.1 x 102 ± 0.7 x 102 2.4 x 102 ± 0.7 x 102 0.7 ± 0.1 * 
MCP-1 1.1 ± 0.3 1.0 ± 0.3 NA ** 
Insulin receptor 1.6 x 102 ± 0.5 x 102 3.1 x 102 ± 0.6 x 102 3.1 ± 0.7 * 
 
Values are expressed as mean ± SEM. Transcript quantities are normalised to GAPDH and expressed relative to 
an internal calibrator. 
a mRNA expression higher in visceral fat than subcutaneous fat (P<0.05) 
b mRNA expression higher in visceral fat than subcutaneous fat (P<0.01) 
c mRNA expression higher in visceral fat than subcutaneous fat (P<0.001) 
* mRNA expression lower in skeletal muscle than in subcutaneous and visceral fat (0.05<P<0.001) 
** Not available 
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Figure legends 
 
Fig. 1. Partial feline-specific mRNA sequences. The mRNA product size is indicated. For 
each feline mRNA product the expected exon position within the corresponding gene is 
indicated according to complete canine and human sequences. Exons are alternatively 
depicted in bold and normal type. 
 
Fig. 2. Deduced feline-specific protein sequences. Differing amino acids are specified for 
canine and human sequences. Identical amino acids are indicated by a horizontal line. 
